Trump’s drug strategy aims to bolster addiction services — despite gutting government support

The White House released its National Drug Control Strategy on May 4, a 195-page document outlining plans to combat the U.S. drug crisis by prioritizing addiction treatment over drug availability, preventing youth addiction, and reducing overdose deaths. Public health experts and recovery advocates support the strategy’s broad goals, including easier treatment access and expanded recovery support, but question its feasibility given the administration’s recent actions. Since 2000, over 1.1 million people have died from drug overdoses in the U.S., with elevated rates among Black and Native American communities. The strategy’s first section focuses on law enforcement, framing drug cartels as ‘foreign terrorist organizations’ and promoting AI-driven drug screening at borders and wastewater testing to detect illegal drug use nationwide. The second half shifts to demand reduction, emphasizing prevention, treatment, and recovery support. However, critics highlight inconsistencies: the administration has cut Medicaid funding, eliminated addiction research grants, and phased out harm reduction programs, while mass layoffs of federal employees have reduced workforce capacity. Libby Jones of the Global Health Advocacy Incubator noted the disconnect between the strategy’s stated priorities and actual funding decisions. The National Drug Control Strategy is published every two years, serving as a federal blueprint for addressing addiction. While it aligns with public health consensus on treatment and recovery, past policies—including enforcement-heavy approaches and defunding of critical programs—have hindered progress. Experts warn that without restored funding and policy alignment, the strategy’s goals risk remaining unfulfilled.